Search research articles
Contact Us
Filters
Showing results (11-20 of 315) with videos related to
Page
of 32
Sort By:
Der Internist
|
July 1, 1980
[Pro and con: Aggressive or conventional treatment of chronic myelogenous leukemia. Arguments in favor of aggressive treatment]
M Andreeff, B D Clarkson
Leukemia Research
|
September 1, 1992
Flow cytometric analysis of cytokinetics of L3-acute lymphoblastic leukemia/lymphoma
S M Lichtman, M Andreeff
Hematology/Oncology Clinics of North America
|
August 1, 1994
Flow cytometry. Clinical and research applications in hematologic malignancies
Y O Huh, M Andreeff
Der Internist
|
July 1, 1980
[Summary: Therapy of chronic myelogenous leukemia--prognosis]
K P Hellriegel, M Andreeff
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1983
Cell survival kinetics in peripheral blood and bone marrow during total body irradiation for marrow transplantation
B Shank, M Andreeff, D Li
Handbook of Experimental Pharmacology
|
June 8, 2007
The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles
B Hall, M Andreeff, F Marini
Deutsche Medizinische Wochenschrift (1946)
|
January 4, 1985
[Oncogens and cancer. Review and a new method for measuring the gene expression in relation to the cell cycle]
M Andreeff, J Bressler, P Higgins
Chemical Immunology
|
June 14, 2000
CD38 in hematopoietic malignancies
M Konopleva, I Rissling, M Andreeff
Annals of the New York Academy of Sciences
|
January 1, 1986
Prognostic value of DNA/RNA flow cytometry in myeloblastic and lymphoblastic leukemia in adults: RNA content and S-phase predict remission duration and survival in multi-variate analysis
M Andreeff, G Assing, C Cirrincione
Natural Immunity
|
January 1, 1996
Bcl-2 is expressed in human natural killer cells and is regulated by interleukin-2
S Jiang, R Munker, M Andreeff
Page
of 32
Search research articles
Search
Showing results (11-20 of 315) with videos related to
Sort By:
Page
of 32
Der Internist
|
July 1, 1980
[Pro and con: Aggressive or conventional treatment of chronic myelogenous leukemia. Arguments in favor of aggressive treatment]
M Andreeff, B D Clarkson
Leukemia Research
|
September 1, 1992
Flow cytometric analysis of cytokinetics of L3-acute lymphoblastic leukemia/lymphoma
S M Lichtman, M Andreeff
Hematology/Oncology Clinics of North America
|
August 1, 1994
Flow cytometry. Clinical and research applications in hematologic malignancies
Y O Huh, M Andreeff
Der Internist
|
July 1, 1980
[Summary: Therapy of chronic myelogenous leukemia--prognosis]
K P Hellriegel, M Andreeff
International Journal of Radiation Oncology, Biology, Physics
|
November 1, 1983
Cell survival kinetics in peripheral blood and bone marrow during total body irradiation for marrow transplantation
B Shank, M Andreeff, D Li
Handbook of Experimental Pharmacology
|
June 8, 2007
The participation of mesenchymal stem cells in tumor stroma formation and their application as targeted-gene delivery vehicles
B Hall, M Andreeff, F Marini
Deutsche Medizinische Wochenschrift (1946)
|
January 4, 1985
[Oncogens and cancer. Review and a new method for measuring the gene expression in relation to the cell cycle]
M Andreeff, J Bressler, P Higgins
Chemical Immunology
|
June 14, 2000
CD38 in hematopoietic malignancies
M Konopleva, I Rissling, M Andreeff
Annals of the New York Academy of Sciences
|
January 1, 1986
Prognostic value of DNA/RNA flow cytometry in myeloblastic and lymphoblastic leukemia in adults: RNA content and S-phase predict remission duration and survival in multi-variate analysis
M Andreeff, G Assing, C Cirrincione
Natural Immunity
|
January 1, 1996
Bcl-2 is expressed in human natural killer cells and is regulated by interleukin-2
S Jiang, R Munker, M Andreeff
Page
of 32